Literature DB >> 15577462

Frank Stinchfield Award. Titanium surface with biologic activity against infection.

Javad Parvizi1, Eric Wickstrom, Allen R Zeiger, Christopher S Adams, Irving M Shapiro, James J Purtill, Peter F Sharkey, William J Hozack, Richard H Rothman, Noreen J Hickok.   

Abstract

Despite immense improvements, periprosthetic infection continues to compromise the result of otherwise successful joint arthroplasty. There are various limitations in the treatment of periprosthetic infection, the most important of which is the inability to deliver antibiotics to the local tissue without the need for intravenous administration. We have developed a novel route to covalently tether vancomycin to a metal (titanium) surface, which showed effective bactericidal activity because of a vancomycin coupling. The chemistry of tethering does not affect the biological activity of the biofactors that are attached to the metal surface. This technology holds great promise for the manufacturing of "smart" implants that can be self protective against periprosthetic infection, or can be used for the treatment of periprosthetic infections when they occur.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15577462     DOI: 10.1097/01.blo.0000150116.65231.45

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  13 in total

1.  Local antibiotic therapy in osteomyelitis.

Authors:  Jaspaul S Gogia; John P Meehan; Paul E Di Cesare; Amir A Jamali
Journal:  Semin Plast Surg       Date:  2009-05       Impact factor: 2.314

2.  Total hip arthroplasty at the rothman institute.

Authors:  Matthew S Austin; Carlos A Higuera; Richard H Rothman
Journal:  HSS J       Date:  2012-04-17

3.  TiO2-containing and ZnO-containing borosilicate glass-a novel thin glass with exceptional antibiofilm performances to prevent microfouling.

Authors:  Mareike Klinger-Strobel; Oliwia Makarewicz; Mathias W Pletz; Andreas Stallmach; Christian Lautenschläger
Journal:  J Mater Sci Mater Med       Date:  2016-10-17       Impact factor: 3.896

4.  Silver nanoparticle deposited implants to treat osteomyelitis.

Authors:  Samit Kumar Nandi; Anish Shivaram; Susmita Bose; Amit Bandyopadhyay
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2017-05-15       Impact factor: 3.368

5.  Tetracycline tethered to titanium inhibits colonization by Gram-negative bacteria.

Authors:  Helen Davidson; Martin Poon; Ray Saunders; Irving M Shapiro; Noreen J Hickok; Christopher S Adams
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2014-11-12       Impact factor: 3.368

Review 6.  Immobilized antibiotics to prevent orthopaedic implant infections.

Authors:  Noreen J Hickok; Irving M Shapiro
Journal:  Adv Drug Deliv Rev       Date:  2012-04-04       Impact factor: 15.470

7.  Inhibition of Staphylococcus epidermidis biofilms using polymerizable vancomycin derivatives.

Authors:  McKinley C Lawson; Kevin C Hoth; Cole A Deforest; Christopher N Bowman; Kristi S Anseth
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

8.  Polymerizable vancomycin derivatives for bactericidal biomaterial surface modification: structure-function evaluation.

Authors:  McKinley C Lawson; Richard Shoemaker; Kevin B Hoth; Christopher N Bowman; Kristi S Anseth
Journal:  Biomacromolecules       Date:  2009-08-10       Impact factor: 6.988

9.  Vancomycin-Loaded Collagen/Hydroxyapatite Layers Electrospun on 3D Printed Titanium Implants Prevent Bone Destruction Associated with S. epidermidis Infection and Enhance Osseointegration.

Authors:  Tomáš Suchý; Lucie Vištejnová; Monika Šupová; Pavel Klein; Martin Bartoš; Yaroslav Kolinko; Tereza Blassová; Zbyněk Tonar; Marek Pokorný; Zbyněk Sucharda; Margit Žaloudková; František Denk; Rastislav Ballay; Štefan Juhás; Jana Juhásová; Eva Klapková; Lukáš Horný; Radek Sedláček; Tomáš Grus; Zdeněk Čejka; Zdeněk Čejka; Kateřina Chudějová; Jaroslav Hrabák
Journal:  Biomedicines       Date:  2021-05-10

10.  Titanium-tethered vancomycin prevents resistance to rifampicin in Staphylococcus aureus in vitro.

Authors:  Martin Rottman; Joel Goldberg; S Adam Hacking
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.